secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0001193125-24-037078
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex implements 1-for-14 reverse stock split to regain Nasdaq minimum bid price compliance
--------------------------------------------------------------------------------

- Split effective 5:00 p.m. ET Feb 19, 2024; shares trade split-adjusted from Feb 20.
- Ratio 1-for-14, approved by board and stockholders; new CUSIP 918640301.
- Complying with $1.00 minimum bid price required by Nasdaq by March 4, 2024.
- Fractional shares rounded up; authorized shares unchanged; equity awards adjusted.
- Shares continue trading under symbol VCNX; transfer agent is Computershare.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524037078/0001193125-24-037078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312524037078/d754295d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-037078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer